Tetroxoprim
From Wikipedia, the free encyclopedia
Systematic (IUPAC) name | |
---|---|
5-[3,5-Dimethoxy-4-(2-methoxyethoxy)benzyl]pyrimidine-2,4-diamine | |
Clinical data | |
Legal status | ? |
Identifiers | |
CAS number | 53808-87-0 |
ATC code | J01EE06 (with sulfadiazine) |
PubChem | CID 65450 |
UNII | 5R6712AY0K |
KEGG | D06097 |
ChEMBL | CHEMBL32039 |
Chemical data | |
Formula | C16H22N4O4 |
Mol. mass | 334.70 g/mol |
SMILES
| |
(what is this?) (verify) | |
Tetroxoprim (INN) is a derivative of trimethoprim. It was first described in 1979.[1]
References
|
This article is issued from Wikipedia. The text is available under the Creative Commons Attribution/Share Alike; additional terms may apply for the media files.